Quick Answer
Summit Therapeutics Inc. reported Gross Profit of -$25.33 million for the year ending 2019.
- Summit Therapeutics Inc. showed a decrease of -1,047.7% in Gross Profit from 2019 to 2019.
- This data is from Summit Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on April 30, 2020.
- XBRL data for this metric is available from 2016 to 2019 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2016 to 2019), Summit Therapeutics Inc.'s Gross Profit has declined by 24.5%.
- Historical annual values: Fiscal year 2019: -$25.33 million | Fiscal year 2019: $2.67 million | Fiscal year 2018: -$25.83 million | Fiscal year 2017: -$24.85 million | Fiscal year 2016: -$20.35 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: